PDE5A and cardiac hypertrophy: As expected, the analysis showed that 26G TAC induced substantial chamber dilatation and development of moderate cardiac hypertrophy with reduced left ventricular systolic function in fractional shortening (FS%) and ejection fraction (EF%) in Pde5a+/+ mice (Fig 2A and B).